RCT | Efficacy and safety of Risankizumab for active psoriatic arthritis
18 Jan, 2023 | 14:04h | UTCCommentary: Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis – HealthDay
Commentary: Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis – HealthDay